Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Evaluation of Emerging Novel Treatments for Infection Prophylaxis in Total Joint Replacement (PREVENT-iT)

NCT06126614 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT06126614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection Prophylaxis in Total Joint Replacement (PREVENT-iT)
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 3
Overall status
Recruiting
Start date
May 7, 2024
Completion date
November 30, 2028
Enrollment
21,006 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

periprosthetic joint infection